TGTX - TG THERAPEUTICS, INC.
29.27
0.240 0.820%
Share volume: 1,204,235
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$29.03
0.24
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-09-2024 | 11-07-2024 | 03-03-2025 | 05-09-2025 | 08-08-2025 | 11-05-2025 | 02-27-2026 | |
| Cash flow financing | 10.000 K | 135.000 K | 134.454 M | -6.072 M | -6.102 M | -6.443 M | -78.242 M | 1.058 M | |
| Other financing cash flows | 0.000 | 135.000 K | 199.000 K | -106.983 M | 21.000 K | 432.000 K | 0.000 | 1.058 M | |
| Cash flow | -8.207 M | 7.436 M | 112.915 M | -15.925 M | -47.751 M | -2.999 M | -55.032 M | 5.080 M | |
| Net income | -10.707 M | 6.879 M | 3.880 M | 23.331 M | 5.060 M | 28.187 M | 390.895 M | 23.037 M | |
| Depreciation | 29.000 K | 19.000 K | 11.000 K | 9.000 K | 8.000 K | 13.000 K | 17.000 K | 21.000 K | |
| Changes in inventories | 77.719 M | 0.000 | 0.000 | 0.000 | 46.305 M | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 64.982 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -9.255 M | 1.765 M | -9.334 M | 15.788 M | -12.934 M | -3.992 M | 46.363 M | -15.638 M | |
| Net Borrowings | -116.554 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 21.000 K | 25.000 K | 42.000 K | 80.000 K | 67.000 K | |
| Cash Change | 209.785 M | 7.436 M | 112.915 M | -15.925 M | -47.751 M | -2.999 M | -55.032 M | 5.080 M |